Frank Bulens
Partner @ imec.xpand
Leuven, Belgium
Frank Bulens is a seed investor at imec.xpand in Leuven focused on Health Care and Medical Device. Frank Bulens is based out of Leuven, Vlaams-Brabant, and is the partner of imec.xpand. Frank previously worked at Indigo as a board member. Frank Bulens attended KU Leuven.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Frank Bulens invests in
Stages Frank Bulens invests in
Countries Frank Bulens invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (50%)
- Medical Device 3 (50%)
- Biotechnology 2 (33%)
- Life Science 1 (17%)
- Neuroscience 1 (17%)
Stage
- Seed 2 (33%)
- Series A 2 (33%)
- Series B 1 (17%)
Country
- Belgium 2 (33%)
- Spain 1 (17%)
- Ireland 1 (17%)
- Switzerland 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. | $49.8M / Series B / Oct 29, 2024 | ||
| OneProjects is an Irish-German cardiac imaging specialist. | $21.8M / Series A / Dec 18, 2023 | ||
| Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology. | $14.5M / Series A / Sep 28, 2023 | ||
| Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood. | $10.7M / Seed / Sep 05, 2023 | ||
| OneProjects is an Irish-German cardiac imaging specialist. | $8M / Series A / Oct 14, 2021 | ||
| Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders. | $7.3M / Seed / Jul 08, 2021 |
Co-Investors
About imec.xpand
Imec.xpand is an independently managed, game-changing way to enable early-stage nano electronics-based innovation powered by imec, the world-leading R&D hub for nanoelectronics and digital technology.
imec.xpand Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Frank Bulens
Partner
|
|||
Tom Vanhoutte
Partner, Founder & Managing Partner
|
|||
Cyril Vancura
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Frank Bulens invest in?
Frank Bulens invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Frank Bulens?
Public channels for Frank Bulens include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Frank Bulens last invest?
The most recent investment recorded for Frank Bulens closed in Oct 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
